Christopher York

Christopher York

Presidente en Turnpoint Medical Devices, Inc. .

63 años
Health Services
Finance
Commercial Services

Perfil

Christopher J.
York
was the founder of InfuScience, Inc. (founded in 2006) where he held the title of Chief Executive Officer in 2009.
He is currently the Chairman at Turnpoint Medical Devices, Inc., a Partner at SLR Capital Partners LLC (since 2023), and an Operating Partner at Shore Capital Partners LLC.
In his former positions, Mr. York served as the Chief Executive Officer & Director at Critical Care Systems, Inc., President & Chief Executive Officer at Gateway Homecare, Inc., Chief Executive Officer at Optum Infusion Services 308 LLC, Managing Director & Equity Research Analyst at JMP Securities LLC (from 2012 to 2020), Director at BriovaRx Infusion Services LLC, and Chief Operating Officer at Coram Healthcare Corp.
Mr. York obtained his undergraduate degree from the University of Wisconsin.

Cargos activos de Christopher York

EmpresasCargoInicio
Presidente -
Inversor de Capital Privado -
Inversor de Capital Privado 18/09/2023
Todos los cargos activos de Christopher York

Antiguos cargos conocidos de Christopher York.

EmpresasCargoFin
Corporate Officer/Principal 01/01/2020
Director/Miembro de la Junta -
Director Ejecutivo -
Director de Operaciones -
Presidente -
Ver el detalle de la experiencia de Christopher York.

Formación de Christopher York.

University of Wisconsin Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Christopher York.

Relaciones

100 +

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas10

Finance

Commercial Services

Health Technology

Health Services

Health Services

Health Services

Health Services

Health Services

Finance

Finance

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Christopher York
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA